Amber R. Douglass, PharmD, BCPS, BCPP
CPNP Programming Committee Member
Alcohol use disorder continues to be a condition that is detrimentally affecting the lives of many Americans.1,2 Mortality data is concerning with rates of alcohol-induced deaths in adults aged 25 and older on the rise.3 With the expense of inpatient hospitalization and stigma of mental health treatment being deterring factors in those seeking care, it’s important to utilize ambulatory management of these disease states when feasible. Those with mild or moderate alcohol withdrawal symptoms may be treated as outpatients, which reduces costs and interruption of daily responsibilities.2 Pharmacists can play a vital role in choosing appropriate therapeutic management options for ambulatory detoxification from alcohol.4.5 This CPNP 2022 session is designed to provide education on evidence-based treatment strategies and pharmacotherapy plans for managing alcohol withdrawal in the outpatient setting.
The learning objectives for this program are:
The Programming Committee is excited to have one of our own CPNP members, Troy A. Moore, MS, BCPP, assist with navigating treatment options for alcohol withdrawal in the outpatient setting.
Dr. Moore received his PharmD from the University of New Mexico College of Pharmacy in 2003. He subsequently attended the University of Texas at Austin College of Pharmacy, receiving his Master of Science in Pharmacy in 2005 while completing a 2-year Psychiatric Pharmacy Residency at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. In 2010, he joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry where he served the Substance Abuse and Domiciliary Programs. Dr. Moore joined the VA Eastern Colorado Health Care System (ECHCS) in December 2018. He is the author of numerous publications, including the Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update and Ambulatory detoxification in alcohol use disorder and opioid use disorder. He is a reviewer for multiple psychiatric and pharmacy journals. He is currently the Director of the ASHP accredited PGY-1 Pharmacy Residency at VA ECHCS, serves as the Co-Chair of the VHA PBM CPPO Substance Use Disorder Subject Matter Expert Workgroup, member of the CPNP Substance Use Disorders committee, and member of the ECHCS Research and Development Committee. Dr. Moore previously served as the Director of the ASHP accredited PGY-2 Psychiatric Pharmacy Residency at STVHCS, Co-Director of the Advanced Fellowship in Addiction Treatment at STVHCS, Chair of the Board of Pharmacy Specialties Specialty Council on Psychiatric Pharmacy, the Member-at-Large on the Board of Director for CPNP, and served as a handling editor for the Mental Health Clinician.
References